Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads In FDA Actions

FDA Actions for September/October 2018

More must reads

FDA Actions for July/August 2018

FDA Approves Perseris for Schizophrenia, FDA news release; 2018 Jul 27

FDA Approves New Dosing Formulation for Nuplazid, Acadia Pharmaceuticals Inc. news release; 2018 Jun 29

FDA Approves Initiation Drug for Schizophrenia, Alkermes plc news release; 2018 Jul 2

More must reads

FDA Actions for May/June 2018

FDA Approves Generic Versions of Suboxone , FDA Web site; 2018 Jun 14

FDA Approves Lucemyra for Opioid Withdrawal, FDA Web site; 2018 May 16

More must reads

FDA Actions for November/December 2017

FDA Approves Injectable Form of Buprenorphine, FDA news release; 2017 Nov 30

FDA Grants Approval for Opioid Withdrawal Device, FDA news release; 2017 Nov 15

FDA Approves First US Digital Medicine System, FDA news release; 2017 Nov 14

FDA Approves Vraylar for Schizophrenia in Adults, Allergan plc news release; 2017 Nov 13

More must reads

FDA Actions for September/October 2017

FDA Approves ADHD Drug for Patients 6 and Older, Neos Therapeutics news release; 2017 Sep 15

More must reads

Pages